Patent assignee · SE · COMPANY

CAMURUS AB

39Patents
36Active
39Granted
53Portfolio score

Filing activity: Nov 14, 1988 → Oct 28, 2024 · 14 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8541400B2 Compositions forming non-lamellar dispersions Human Necessities 61 Active
US8236755B2 Opioid depot formulations Human Necessities 35 Active
US8097239B2 Controlled-release formulations Human Necessities 35 Active
US8236292B2 Liquid depot formulations Human Necessities 27 Active
US8546326B2 Glp-1 analogue formulations Human Necessities 20 Active
US8182834B2 Ternary non-lamellar lipid compositions Human Necessities 12 Active
US8187629B2 Non-lamellar compositions of DOPE and P80 Human Necessities 12 Expired
US5001062A Antithrombogenic article containing lysozyme and heparin adsorbed on a substrate Human Necessities 10 Expired
US9585959B2 Robust controlled-release formulations Human Necessities 9 Active
US5260282A Saliva substitute Human Necessities 8 Expired
US8920782B2 Topical bioadhesive formulations Human Necessities 6 Active
US9526788B2 Pharmaceutical lipid compositions Human Necessities 6 Active
US9968680B2 Topical bioadhesive formulations Human Necessities 5 Active
US9937164B2 Opioid formulations Human Necessities 5 Active
US9649382B2 Topical bioadhesive formulations Human Necessities 5 Active
US10912772B2 Opioid formulations Human Necessities 4 Active
US10688148B2 Formulations containing a somatostatin receptor agonist Emerging Cross-Sectional Technologies 4 Active
US11135215B2 Opioid formulations Human Necessities 2 Active
US11110084B2 Opioid formulations Human Necessities 2 Active
US9974861B2 Peptide slow-release formulations Human Necessities 2 Active
US11135264B2 Formulations containing a somatostatin receptor agonist Emerging Cross-Sectional Technologies 1 Active
US8865021B2 Compositions of lipids and cationic peptides Emerging Cross-Sectional Technologies 1 Active
US9820934B2 Acid containing lipid formulations Human Necessities 1 Active
US9067190B2 Method for loading amphiphile particles with active agents Performing Operations; Transporting 1 Active
US12029813B2 Injectable buprenorphine formulation Human Necessities 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.